A detailed history of Legal & General Group PLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Legal & General Group PLC holds 13,482,107 shares of BSX stock, worth $1.23 Billion. This represents 0.24% of its overall portfolio holdings.

Number of Shares
13,482,107
Previous 13,482,107 -0.0%
Holding current value
$1.23 Billion
Previous $1.13 Billion -0.0%
% of portfolio
0.24%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $32.2 Million - $37 Million
-440,666 Reduced 3.17%
13,482,107 $1.13 Billion
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $24.3 Million - $28 Million
360,793 Added 2.66%
13,922,773 $1.07 Billion
Q1 2024

Jul 01, 2024

BUY
$57.6 - $68.62 $7.06 Million - $8.41 Million
122,622 Added 0.91%
13,561,980 $929 Million
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $4.89 Million - $5.82 Million
-84,841 Reduced 0.63%
13,439,358 $920 Million
Q4 2023

Feb 15, 2024

BUY
$48.64 - $57.81 $110 Million - $131 Million
2,270,831 Added 20.18%
13,524,199 $782 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $12.6 Million - $13.8 Million
-251,576 Reduced 2.19%
11,253,368 $594 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $36.9 Million - $40.6 Million
742,518 Added 6.9%
11,504,944 $622 Million
Q1 2023

May 15, 2023

BUY
$45.09 - $50.03 $10.7 Million - $11.8 Million
236,481 Added 2.25%
10,762,426 $538 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $12.6 Million - $15.1 Million
-319,607 Reduced 2.95%
10,525,945 $487 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $11.8 Million - $35.2 Million
-320,625 Reduced 2.87%
10,845,552 $420 Million
Q2 2022

Aug 22, 2022

BUY
$35.24 - $47.1 $14.4 Million - $19.3 Million
409,391 Added 3.81%
11,166,177 $416 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $36 Million - $39.7 Million
880,914 Added 8.92%
10,756,786 $476 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $15.2 Million - $17.9 Million
-398,544 Reduced 3.88%
9,875,872 $420 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $22.7 Million - $25.3 Million
551,217 Added 5.67%
10,274,416 $446 Million
Q2 2021

Aug 12, 2021

BUY
$38.58 - $44.24 $20.9 Million - $23.9 Million
541,219 Added 5.89%
9,723,199 $416 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $3.89 Million - $4.38 Million
-110,300 Reduced 1.19%
9,181,980 $355 Million
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $7.88 Million - $9.97 Million
237,625 Added 2.62%
9,292,280 $334 Million
Q3 2020

Nov 13, 2020

SELL
$34.44 - $42.23 $612,515 - $751,060
-17,785 Reduced 0.2%
9,054,655 $346 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $2.91 Million - $3.78 Million
-96,545 Reduced 1.05%
9,072,440 $319 Million
Q1 2020

May 14, 2020

BUY
$25.83 - $45.71 $10 Million - $17.7 Million
387,556 Added 4.41%
9,168,985 $300 Million
Q4 2019

Feb 13, 2020

BUY
$37.87 - $45.37 $8.58 Million - $10.3 Million
226,587 Added 2.65%
8,781,429 $397 Million
Q3 2019

Nov 13, 2019

SELL
$40.31 - $43.45 $1.35 Million - $1.45 Million
-33,425 Reduced 0.39%
8,554,842 $348 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $628,345 - $773,597
17,999 Added 0.21%
8,588,267 $369 Million
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $51.6 Million - $63.9 Million
1,567,394 Added 22.38%
8,570,268 $329 Million
Q4 2018

Feb 15, 2019

BUY
$31.73 - $39.04 $19 Million - $23.4 Million
598,647 Added 9.35%
7,002,874 $247 Million
Q3 2018

Nov 20, 2018

BUY
$32.83 - $38.63 $9.21 Million - $10.8 Million
280,645 Added 4.58%
6,404,227 $247 Million
Q2 2018

Aug 10, 2018

SELL
$26.84 - $34.32 $7 Million - $8.95 Million
-260,671 Reduced 4.08%
6,123,582 $200 Million
Q1 2018

May 17, 2018

SELL
$25.2 - $28.54 $7.42 Million - $8.4 Million
-294,307 Reduced 4.41%
6,384,253 $174 Million
Q4 2017

Feb 13, 2018

BUY
$24.79 - $29.8 $166 Million - $199 Million
6,678,560
6,678,560 $166 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.